Overview

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Status:
Completed
Trial end date:
2018-11-17
Target enrollment:
Participant gender:
Summary
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide compared with AzoptTM
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Valeant Pharmaceuticals International, Inc.
Treatments:
Brinzolamide